Ruocong Zhao - Concepedia

Author

Ruocong Zhao

Guangzhou Institutes of Biomedicine and Health ORCID

Also Known As

R Zhao, R. Zhao, Rongquan Zhao, Rundi Zhao, Ruocong Zhao

Publications

942

Citations

H-Index

Concepts

All Affiliations

Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences University of Chinese Academy of Sciences Guangzhou Regenerative Medicine and Health Guangdong Laboratory Guangdong General Hospital

About

Ruocong Zhao is an author at Guangzhou Institutes of Biomedicine and Health specializing in immunology, immunotherapy, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	185
2	Cell Biology	3	3	185
3	Immunology	3	3	185
4	Autoimmunity	2	2	150
5	Cell Signaling	2	2	82

Ruocong Zhao

Publications

888

Citations

H-Index

Page 1

	Year	Citations
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer Jiang Lv, Ruocong Zhao, Di Wu, Journal of Hematology & Oncology	2019	137
PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells Xinru Wei, Yunxin Lai, Jin Li, OncoImmunology	2017	132
Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells Yunxin Lai, Jianyu Weng, Xuefeng Wei, Leukemia InflammationToll-like ReceptorsCar T CellsCancer ImmunosurveillanceT-regulatory Cell	2017	103
Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells Le Qin, Yunxin Lai, Ruocong Zhao, Journal of Hematology & Oncology	2017	95
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth Le Qin, Ruocong Zhao, Dongmei Chen, Biomarker Research	2020	65
Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer Ruocong Zhao, Yuanbin Cui, Yongfang Zheng, Frontiers in Immunology	2021	58
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia Mengjun Zhong, Rili Gao, Ruocong Zhao, Cell Death and Disease	2022	56
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells Zhiwu Jiang, Rui Liao, Jiang Lv, Leukemia Car T CellsCancer ImmunosurveillanceImmunologyImmunologic MechanismAutoimmunity	2020	47
PSCA is a target of chimeric antigen receptor T cells in gastric cancer Di Wu, Jiang Lv, Ruocong Zhao, Biomarker Research	2020	40
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis Le Qin, Yuanbin Cui, Tingjie Yuan, Nature Communications	2022	40

Page 1